A weekly round-up of the
latest coverage in psychedelics.
Receive the free weekly digest straight to your inbox every week
By signing up, you agree to our privacy policy. You can unsubscribe at any time.
December 23 – 29, 2024
This Week’s Feed, Sponsored by
Clerkenwell Health Clinical Catalyst Program
Clerkenwell Health’s Clinical Catalyst programme provides tailored support that small companies need to accelerate their clinical development.
Successful applicants receive: A free workshop on clinical development and regulatory strategy; grant application support; 20% off CRO services; access to senior expertise and a network of service providers, investors, and researchers.
Applications close January 31st, 2025.
December 16 – 22, 2024
This Week’s Feed, Sponsored by
Psychedelic Science June 16-20-2025
In the spirit of the holiday season, enjoy $50 off all registration types through 12/31 to Psychedelic Science, the most extraordinary week of the psychedelic movement. This is your last chance to save on registrations before prices increase January 10. Don’t miss out on the opportunity to connect, learn, and grow at the world’s largest gathering of the psychedelic community.
Visit www.psychedelicscience.org and use the code PSYCHALPHA25 to take an additional 15% off your registration (valid now through June 16).
Pα+ Psychedelic Bulletin #183
Psychedelic Alpha ↗
- Reflecting on UW Madison’s Fourth Annual Psychedelic Symposium
- MindMed Doses First Patient in Phase 3 LSD Program
- Beckley Psytech Shares Small Cut of Data from Phase 2a Study of IV Psilocin in MDD
- Trial Suggests Psilocybin Could Help Clinicians With COVID-Related Mental Health Issues
- Naropa Spins Off Psychedelics Centre to Avoid Federal Illegality
- Awakn Life Sciences Set to Be Acquired
- and more…
December 9 – 15, 2024
This Week’s Feed, Sponsored by
OREGON PSYCHEDELIC INSTITUTE
OPI’s 11-week Psilocybin Facilitator Training Program, starting January 21, 2025, offers a rigorous, research-informed curriculum for aspiring leaders in the field of psychedelics.
All students accepted into this inaugural cohort will be granted a $1,200 tuition reduction.
Gain the skills and knowledge needed to advance this transformative field through an expert-led, science-driven education.
Pα+ Psychedelic Bulletin #182
Psychedelic Alpha ↗
- Psychedelics Insiders Draw Up Trump 2.0 Wishlist
- Rick Doblin Reflects on Lykos’ Strategy as MAPS Settles with FDA
- Polish Medical Research Agency Set to Provide PLN 16M ($4M) to Psilocybin Study
- VA Issues Note on Psychedelics for PTSD; Officially Funds Psychedelics Study
- Alleged Killer of UnitedHealth CEO Apparently Interested in Psychedelics
- Other Stories including: MDMA Plus Massed Exposure Therapy Protocol Published; Pollan Pushes Back on RFK Jr. Hype; Greenbrook TMS Stock Slumps Following Q3 Earnings; 30 Magic Mushroom Hops Shutter in Ontario; Expression of Concern Issued Over MAPS/Lykos Journal Article; Relmada Therapeutics’ Phase 3 MDD Drug Fails; and more…
Exclusive: Negev Labs unveils with $30M in assets, striving to build a network of psychedelic biotechs
Endpoints ↗
“The main theme of the companies it wants to build? No tripping.”
Bullish on Chaos: Matt Zorn on How Psychedelics Could Benefit from Trump’s Second Term
Psychedelic Alpha ↗
After years of challenging the U.S. government over its drug laws and their application, lawyer Matt Zorn is bullish about the potential regulatory openings that an incoming Trump administration might present. Here, he discusses the types of ‘deeper questions’ we might ask about the U.S. system of drug and medicines regulation and how we might begin to reimagine it.
Psilocybin industry will focus on fine-tuning first-in-the-nation program in 2025
Oregon Capital Chronicle ↗
December 2 – 8, 2024
Interview: Inside the FDA’s Psychedelics Journey: Javier Muniz, MD on Breakthroughs, Challenges, and the Future of the Field
Psychedelic Alpha ↗
Psychedelic Alpha’s Josh Hardman speaks with Javier Muniz, MD, who recently left his post as Associate Director at the FDA’s Division of Psychiatry. In that role, Muniz was at the heart of the agency’s psychedelics learning journey and helped formulate its view on thorny topics in psychedelic drug development like functional unblinding and the role of psychotherapy. This interview is far-reaching and provides a unique look into both the mind of the regulator, but also Muniz’s own views on psychedelics, now that he is unencumbered by his position in the agency.
NYC Memorial Planned for Lucid News Co-Founder Ken Jordan
Lucid News ↗
The memorial will take place on Thursday, December 19, from 5:30-8:00 pm. More info and RSVP.
Aaron Rodgers: Enigma (Trailer)
Netflix (YouTube) ↗
The trailer for a Netflix documentary which follows NFL star Aaron Rodgers has been released, with the film set to drop on December 17th. It prominently features his use of ayahuasca.
November 25 – December 1, 2024
Interviews: Meet the Team Who Challenged the DEA on DOI and DOC
Psychedelic Alpha ↗
Dr. Alaina M. Jaster profiles the scientists, advocates and lawyers challenging the agency’s proposed scheduling of two phenethylamine psychedelics.
Psychedelics and Entactogens: Call for Papers (Closes June 30, 2025)
Journal of Medicinal Chemistry ↗
Ancient Egyptians Drank Psychedelic Concoctions From This 2,000-Year-Old Mug, Study Finds
Smithsonian Magazine ↗
Pα+
An insider’s guide to the business,
policy and science of psychedelics.
Basic
Free subscribers receive a weekly round-up of news on psychedelics, as well as the occasional article.
Receive regular bulletins, articles, interviews with insiders and quick-take analysis of major stories and developments.
Teams
Teams, groups and corporate pricing plans are available, please get in touch via email to learn more.
Benefits
Front-row access to the psychedelics space: breaking bulletins, in-depth articles, insider interviews and sharp analysis of the moments that matter—from major trial results and funding rounds to policy shifts shaping the future. Plus, full access to our complete archive and Library.
Learn More| Free | ||
|---|---|---|
| Weekly Psychedelic News Feed | ||
| Occasional Articles & Free Resources | ||
| Psychedelic Bulletins (In-Depth Briefings, Multiple per Month) | ||
| Quick-Take Analysis of Major Developments | ||
| In-Depth Articles & Deep Dives | ||
| Exclusive Interviews with Insiders & KOLs | ||
| Quarterly Video Briefings | ||
| Exclusive Tools & Data Resources | ||
| Library of Primers & Explainers | ||
|
Subscribe Now |
||